Polypharmacy in Psychiatry Practice, Volume II

<p>About the Editor<p>Preface  </p><p>Contributors to Volume II</p><p>Part 1. Antipsychotic polypharmacy  </p><p>1.      Antipsychotic polypharmacy for schizophrenia: 'Secret sauce' or 'wild abandon'? Peter F. Buckley<p>2.      Antipsychotic polypharmacy in USA.  Anand K. Pandurangi, John Vernon</p><p>3.      Antipsychotic polypharmacy in Czech Republic and in Ukraine. Viktor P. Samokhvalov, Oxana Samokhvalova, Viktoria  A. Verbenko, Georgij N. Verbenko</p><p>4.      Antipsychotic polypharmacy in residential facilities in Italy: the gap between recommendations and real world practice. Lucio Ghio, Werner Natta, Simona Gotelli, Luigi Ferrannini</p><p>5.      Antipsychotic polypharmacy and associated phenomena in patients with schizophrenia: Rational or irrational? KH Yong, Norman Sartorius, Kang Sim</p><p>6.      Antipsychotic polypharmacy in schizophrenia. How to counteract this common practice? Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Masaru Mimura <p>7.      Clozapine combinations in treatment-resistant schizophrenia patients. Vladimir Lerner and Chanoch Miodownik</p><p>8.      Metabolic syndrome and antipsychotic polypharmacy. Fuminari Misawa, Fujii Yasuo, Yasuyuki Okumura, Hiroto Ito</p><p> </p><p>Part 2. Polypharmacy for other psychiatric conditions</p><p>9.      Evidence based combination therapy for bipolar disorder. Stamatia Magiria, Melina Siamouli, Xenia Gonda, Apostolos Iacovides, Konstantinos N. Fountoulakis</p><p>10.  Antidepressant combination strategies for major depressive disorder. André F. Carvalho, Danielle S. Macêdo, Thomas N. Hyphantis, Roger S. McIntyre<p>11.  Herbal remedies and nutraceuticals as augmentation or adjunct for mood and anxiety disorders: evidence for benefit and risk. Arun V. Ravindran and Tricia L. da Silva</p>12.  Obsessive-compulsive syndromes in schizophrenia: A case for polypharmacy? Frederike Schirmbeck and Mathias Zink</p><p>13.  Polypharmacy and potentially inappropriate medication use among elders with dementia. Jan Lužný<p>14.  The role of polypharmacy in bipolar disorder treatment guidelines. Heinz Grunze</p><p>Appendix             Rena Kurs<p>1.      Annotated bibliography on polypharmacy</p><p>2.      List of Psychotropic Medications  </p><p>Contents to Volume I </p><p>Contributors to Volume I</p><p>Index</p>